C
RARE icon

Covestor’s Ultragenyx Pharmaceutical RARE Stock Holding History

Covestor’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Buy
310
+19
+7% +$472 0.01% 1616
2026
Q1 		$6K Sell
291
-1,165
-80% -$26.2K ﹤0.01% 1745
2025
Q4 		$34K Sell
1,456
-331
-19% -$10.9K 0.02% 1054
2025
Q3 		$54K Buy
1,787
+369
+26% +$11.1K 0.03% 872
2025
Q2 		$52K Sell
1,418
-293
-17% -$10.6K 0.03% 881
2025
Q1 		$62K Buy
1,711
+795
+87% +$33.1K 0.04% 755
2024
Q4 		$39K Buy
916
+225
+33% +$11.2K 0.02% 945
2024
Q3 		$38K Buy
691
+2
+0.3% +$102 0.02% 971
2024
Q2 		$28K Sell
689
-306
-31% -$13.1K 0.02% 1073
2024
Q1 		$46K Sell
995
-216
-18% -$10.2K 0.03% 922
2023
Q4 		$58K Buy
1,211
+463
+62% +$17.9K 0.04% 782
2023
Q3 		$27K Buy
748
+596
+392% +$23.6K 0.02% 1016
2023
Q2 		$7K Buy
152
+22
+17% +$1.02K 0.01% 1642
2023
Q1 		$5K Buy
130
+1
+0.8% +$43 ﹤0.01% 1573
2022
Q4 		$6K Sell
129
-40
-24% -$1.57K ﹤0.01% 1534
2022
Q3 		$7K Buy
169
+45
+36% +$2.31K 0.01% 1409
2022
Q2 		$7K Sell
124
-1
-0.8% -$62 0.01% 1327
2022
Q1 		$9K Buy
125
+54
+76% +$3.76K 0.01% 1362
2021
Q4 		$6K Buy
+71
New +$5.78K 0.01% 1249

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Covestor's RARE Position: Q2 2026 in Review

Covestor increased its Ultragenyx Pharmaceutical (RARE) stake by 6.5% in Q2 2026, buying an estimated $472 and bringing the position to 310 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1616.

Covestor first reported a position in RARE in Q4 2021 and has held it in 19 quarters since. The position peaked at $62K in Q1 2025. 203 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Covestor held 310 shares of Ultragenyx Pharmaceutical worth $10K as of Q2 2026.
  • Covestor bought 19 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $472.
  • Ultragenyx Pharmaceutical made up 0.01% of Covestor's portfolio in Q2 2026, its #1616 holding.
  • Covestor first reported a position in Ultragenyx Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Ultragenyx Pharmaceutical position peaked at $62K in Q1 2025.
  • 203 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.